Cargando…
Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
The assessment of fibrosis in chronic liver diseases using non-invasive methods is an important topic in hepatology. The aim of this study is to identify patients with non-alcoholic fatty liver disease (NAFLD) and advanced liver fibrosis by establishing correlations between biological/ultrasound mar...
Autores principales: | Olteanu, Vasile-Andrei, Balan, Gheorghe G., Timofte, Oana, Dascalu, Cristina Gena, Gologan, Elena, Gilca-Blanariu, Georgiana-Emanuela, Diac, Madalina-Maria, Sandu, Ion, Stefanescu, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498120/ https://www.ncbi.nlm.nih.gov/pubmed/36140537 http://dx.doi.org/10.3390/diagnostics12092136 |
Ejemplares similares
-
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023) -
Magnesium—A Potential Key Player in Inflammatory Bowel Diseases?
por: Gilca-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2022) -
Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017) -
Split-dose or hybrid nonsteroidal anti-inflammatory drugs and N-acetylcysteine therapy for prevention of post-retrograde cholangiopancreatography pancreatitis
por: Pavel, Laura, et al.
Publicado: (2019) -
New Insights into the Role of Trace Elements in IBD
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2018)